Competitive Intelligence as a Strategic Imperative The life sciences industry is evolving at an unprecedented pace—from groundbreaking biotech innovations to rapid shifts in funding, regulation, and market demand. Companies can’t afford to rely on outdated anecdotal…

Competitive Intelligence: A Strategic Imperative for Life Science Instrumentation Companies The life science and analytical instrumentation industry is evolving at an unprecedented pace. With new technologies, emerging applications, and shifting customer demands, companies that rely…

Pharmacodiagnostics is swiftly emerging as a vital player in the global cancer diagnostics market, which soared to nearly $10 billion in revenue in 2024, according to Kalorama Information’s recent report, The World Market for Cancer Diagnostics,…

This blog draws on insights from the Kalorama Information report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029. For further details, please visit the report’s product page HERE. Personalized medicine, also known as…

Prepare for FY2025 with this free, 30-minute live learning session designed for life science professionals looking to understand how Academics plan to navigate an uncertain funding landscape. Watch the recording on-demand as industry expert, Dr.…